Mesirow Financial Investment Management’s Amicus Therapeutics FOLD Stock Holding History

Mesirow Financial Investment Management’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-13,000	Closed	-$188K	–	539
2026 Q1	$188K	Hold	13,000	–	–	﹤0.01%	498
2025 Q4	$185K	Hold	13,000	–	–	﹤0.01%	468
2025 Q3	$102K	Hold	13,000	–	–	﹤0.01%	538
2025 Q2	$74.5K	Hold	13,000	–	–	﹤0.01%	522
2025 Q1	$106K	Sell	13,000 -3,936	-23%	-$36.4K	﹤0.01%	560
2024 Q4	$160K	Hold	16,936	–	–	﹤0.01%	562
2024 Q3	$181K	Sell	16,936 -2,067	-11%	-$22.5K	﹤0.01%	553
2024 Q2	$189K	Sell	19,003 -80	-0.4%	-$821	﹤0.01%	476
2024 Q1	$225K	Sell	19,083 -63	-0.3%	-$806	0.01%	471
2023 Q4	$272K	Buy	+19,146	New	+$217K	0.01%	457

Other funds holding FOLD

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Mesirow Financial Investment Management's FOLD Position: Q2 2026 in Review

Mesirow Financial Investment Management sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 13,000 shares — an estimated $188K sold.

Mesirow Financial Investment Management first reported a position in FOLD in Q4 2023 and held it in 10 quarters. The position peaked at $272K in Q4 2023. 1 fund tracked by Wall St. Rank holds FOLD as of Q2 2026.

Mesirow Financial Investment Management reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
Mesirow Financial Investment Management sold 13,000 Amicus Therapeutics shares in Q2 2026, an estimated $188K.
Mesirow Financial Investment Management first reported a position in Amicus Therapeutics in Q4 2023 and held it in 10 quarters.
Mesirow Financial Investment Management's Amicus Therapeutics position peaked at $272K in Q4 2023.
1 fund tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Mesirow Financial Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.